Effects of Magnesium Enriched Water on Cardiovascular Disease and Diabetes

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CRIS

Registry ID

KCT0009526

Enrollment

Registered

2024-06-13

Start date

2021-10-01

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : We conducted a double-blind, parallel, and randomized clinical trial (Fig. 1). Participants with prehypertension or borderline diabetes (HbA1c = 5.6%), who visited the Suwon-ICOOP

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Adults( men and women) aged 40-75 years with high blood pressure or borderline diabetes

Exclusion criteria

Exclusion criteria: Limited to those who will adhere to the experiment schedule during the experiment period.

Design outcomes

Primary

Measure	Time frame
HbA1C	—

Secondary

Measure	Time frame
Blood pressure, HOMA-IR, Insulin, LDL, HDL, TG, TC, 1-OHP, MDA, CAVI	—

Countries

Korea, Republic of

Contacts

Public ContactMihi Yang

Sookmyung Women's Hospital

myang@sookmyung.ac.kr+82-2-2077-7179

Outcome results